Please login to the form below

Not currently logged in
Email:
Password:

NHS

This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.

Hancock's 'Tech Revolution' for NHS to be limited by budgets

Hancock's 'Tech Revolution' for NHS to be limited by budgets

Health and Social Care Secretary Matt Hancock said: “The tech revolution is coming to the NHS. ... We want this approach to empower the country’s best innovators – inside and outside the NHS.”.

Latest news

More from news
Approximately 310 fully matching, plus 1,114 partially matching documents found.

Latest Intelligence

  • AI UK – one year on AI UK – one year on

    Specific to the UK, this was a role that patients wanted to see taken on by the NHS and the physicians it employs. ... But now all the signs point to an engaged and supportive NHS becoming the driving force behind.

  • The NHS in 2022: how pharma can contribute to new models of care The NHS in 2022: how pharma can contribute to new models of care

    The NHS in 2022: how pharma can contribute to new models of care. ... James Roach on the NHS' biggest challenges, and how the industry can help.

  • Joint working that works Joint working that works

    that joint working was usually more beneficial to the NHS or patients than to themselves. ... It’s essential to align objectives and find the sweet spot where the work will meet patient, NHS and commercial needs.

  • Cancer care – the power of new technologies Cancer care – the power of new technologies

    Last month marked the publication of the seventh NHS England’s annual National Cancer Patient Experience Survey. ... We are continually engaged in conversations with NHS colleagues, exploring ways to help redefine life with cancer.

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    There is also an opportunity to work with the NHS, and Osbourn says the company will search for ways of mutual support. ... and to drive innovation in the NHS. Blockbuster bumps. AstraZeneca has endured some bumpy times as its blockbusters have declined

More from intelligence
Approximately 27 fully matching, plus 125 partially matching documents found.

Latest appointments

More from appointments
Approximately 19 fully matching, plus 82 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 30 fully matching, plus 198 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics